DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Haghighi M, Jahangard L, Mohammad-Beigi H. et al.
In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).
Psychopharmacology (Berl) 2013;
228: 633-640
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.